The Indian drug regulatory authority, Central Drugs Standard Control Organization (CDSCO), has authorized Miqnaf (nafithromycin) as a new treatment for Community-Acquired Bacterial Pneumonia (CABP) in adults. Miqnaf is a rapid, three-day treatment...
The Subject Expert Committee (SEC) operating under the Central Drug Standard Control Organisation (CDSCO) has permitted drug giant Sun Pharma Laboratories to produce and sell Fexuprazan Hydrochloride Tablets 40 mg. Nonetheless, this approval is...
Innovent Biologics, a top-tier biopharmaceutical firm focused on creating, producing, and marketing high-quality drugs for oncology, cardiovascular and metabolic diseases, autoimmune disorders, ophthalmology, and various other serious illnesses...
Akums Drugs and Pharmaceuticals revealed the launch of a new sterile facility focused on manufacturing lyophilised products and injectables, alongside vials, ampoules, eye and ear drops, and form-fill-seal (FFS) products. Lyophilisation involves...
Biocon Pharma Ltd has secured approval from China's National Medical Products Administration (NMPA) for its Tacrolimus capsules available in 0.5mg, 1mg, and 5mg dosages. Tacrolimus, an immunosuppressive medication, is utilized to inhibit organ...
India now represents 60% of worldwide vaccine production and hosts the second-highest number of USFDA-approved manufacturing facilities outside the United States. As investment prospects expand in areas like Bio-Pharma, Bio-Agri, Bio-Industrial...
According to recent data, 54% of advanced biotech laboratories have identified gene-editing research as their main growth engine this year, highlighting the increasing importance of this sector. The worldwide gene therapy market had a valuation of...
Verastem Oncology, a biopharmaceutical company committed to advancing new medicines for patients with cancer, announced that the US Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) under the accelerated...
In terms of government support, the production linked incentive (PLI) initiative and the creation of greenfield projects have been vital in enhancing India's local pharmaceutical sector. Ruchi Sogarwal, head of corporate affairs at Takeda India...
Indian pharmaceutical firms have achieved significant progress in complying with rigorous US Food and Drug Administration (USFDA) standards in 2024, with evidence indicating a reduction in adverse classification results from inspections involving...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")